Ann: Response to ASX Price and Volume Query, page-7

"3. If the answer to question 1 is “no”, is there any other explanation that GMV may have for the recent trading in its securities?

G Medical recently made an announcement to the market on 27 July 2017 with regards to signing a Binding MOU for China Distribution valued at US$67.5M. The obligation to acquire the units commences on the granting of the CFDA certification to G Medical, which is currently in process."

This is how stupid the ASX are, price has risen ever since this ann, that they approved, good reply by GMV